tamu#81095

85

Upload: zwi

Post on 06-Jan-2016

24 views

Category:

Documents


4 download

DESCRIPTION

TAMU#81095. Sig: 11 yr M(c) Mixed Labrador CC: Chronic cough HPI: Cough and expectoration started 1 week ago Vet found hypoalbuminemia on routine blood work PE: Thin but normal. TAMU#81095. PCV =33% (35-54) WBC =11,100/ul (6,-17,000) - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: TAMU#81095
Page 2: TAMU#81095

TAMU #81095

Sig: 11 yr M(c) Mixed Labrador

CC: Chronic cough

HPI: Cough and expectoration started 1

week ago

Vet found hypoalbuminemia on

routine blood work

PE: Thin but normal

Page 3: TAMU#81095

TAMU #81095

PCV = 33% (35-54)

WBC = 11,100/ul (6,-17,000)

Segs = 9,102/ul (3,-12,000)

Bands = 0/ul (< 500)

Lymphs =444/ul (1,-5,000)

Platelets = 187,000/ul (200,-500,000)

Page 4: TAMU#81095

TAMU #81095

BUN = 6 mg/dl (6-20)Creatinine = 0.6 mg/dl (< 2.0)Cholesterol = 51 mg/dl (120-247)Glucose = 81 mg/dl (60-120)Total protein = 5.8 gm/dl (5.5-7.5)Albumin = 1.8 gm/dl (2.5-4.4)ALT = 649 IU/L (< 110)SAP = 320 IU/L (< 130)Bilirubin = 0.1 mg/dl (< 1.0)

Page 5: TAMU#81095

TAMU #81095

Abdominal ultrasound:

“No significant findings”

Page 6: TAMU#81095

IS IT COST-EFFECTIVE OR

PRACTICAL TO BIOPSY THE

LIVER OF AN ASYMPTOMATIC

DOG JUST BECAUSE IT HAS

INCREASED HEPATIC

ENZYMES?

Page 7: TAMU#81095

TAMU #81095

Hepatic biopsy:

SEVERE chronic hepatitis

with marked fibrosis and

scarring; early cirrhotic changes

Page 8: TAMU#81095
Page 9: TAMU#81095

CHRONIC HEPATITISWhat is it?

• Chronic non-septic inflammatory

disease of the liver which has many

different causes

Page 10: TAMU#81095

CHRONIC HEPATITISWhat the clinician needs to know

• Breed predisposition

Page 11: TAMU#81095

CHRONIC HEPATITISWhat the clinician needs to know

• Breed predisposition

• Clinical signs

– chronic illness

Page 12: TAMU#81095

CHRONIC HEPATITISWhat the clinician needs to know

• Breed predisposition

• Clinical signs

– chronic illness

– asymptomatic dog with lab changes

– acute illness

Page 13: TAMU#81095

IMPORTANCE OF THE

WORD “CHRONIC”

CHRONIC HEPATITISWhat the clinician needs to know

Page 14: TAMU#81095

TAMU #149538

One year ago, they found an increased ALT, so they decided to watch and see what would happen ...

Page 15: TAMU#81095

CHRONIC HEPATITISWhat the clinician needs to know

• Breed predisposition

• Clinical signs (or lack there of)

• Absolute necessity of biopsy

Page 16: TAMU#81095

WHAT DO YOU DO

AFTER DIAGNOSING

CHRONIC HEPATITIS?

Page 17: TAMU#81095

Drugs That Cause Hepatic Disease

Corticosteroids

Page 18: TAMU#81095

Drugs That Cause Hepatic Disease

Corticosteroids Acetaminophen

Phenobarbital Primidone

Sulfa drugs Carprofen

Page 19: TAMU#81095

Drugs That Cause Hepatic Disease

Corticosteroids Acetaminophen

Phenobarbital Primidone

Sulfa drugs CarprofenAmiodarone Itraconazole

Ketoconazole DiazepamDoxycycline Methimazole

Azathioprine Phenytoin

Mibolerone Griseofulvin Mitotane Stanozolol

Mebendazole Clavamox

Clindamycin Cimetidine

Page 20: TAMU#81095

CHRONIC HEPATITISCauses

• Drugs

– You REALLY want to catch this

BEFORE biopsy

– sometimes easy to establish cause

and effect

– sometimes hard to establish cause

and effect

Page 21: TAMU#81095

Proceed w ithw orkup

N ot receiving drugs

Patientsignificantly ill

D rugs cannotbe stopped

Stop drugsR echeck A LT

over next 4 w ks

D rugs canbe stopped

Patient notsignificantly ill

R eceiving drugs

Increased A LT

Page 22: TAMU#81095

Proceed w ithw orkup

N ot receiving drugs

Patientsignificantly ill

D rugs cannotbe stopped

Stop drugsR echeck A LT

over next 4 w ks

D rugs canbe stopped

Patient notsignificantly ill

R eceiving drugs

Increased A LT

Page 23: TAMU#81095

Proceed w ithw orkup

N ot receiving drugs

Patientsignificantly ill

D rugs cannotbe stopped

Stop drugsR echeck A LT

over next 4 w ks

D rugs canbe stopped

Patient notsignificantly ill

R eceiving drugs

Increased A LT

Page 24: TAMU#81095

Proceed w ithw orkup

N ot receiving drugs

Patientsignificantly ill

D rugs cannotbe stopped

Stop drugsR echeck A LT

over next 4 w ks

D rugs canbe stopped

Patient notsignificantly ill

R eceiving drugs

Increased A LT

Page 25: TAMU#81095

CHRONIC HEPATITISCopper-associated hepatic disease

• Bedlington terrier

• West Highland white terriers

• Doberman pinschers

• Skye terrier

• Dalmations

• Labrador retrievers

Page 26: TAMU#81095

CHRONIC HEPATITISCauses

• Copper intoxication

– primary (causes hepatic disease –

genetic)

• Innocent copper accumulation

– secondary (caused by hepatic disease)

Page 27: TAMU#81095

TAMU #170148

Centrilobular (zone 3) deposits of copper strongly suggest that copper is the cause of the problem

Page 28: TAMU#81095

CHRONIC HEPATITISTherapy for inflammation/necrosis

• Remove cause – symptomatic

– Chelate copper with d-Penicillamine

(10-15 mg/kg bid, give with food)

– Do not give zinc when administering

copper chelators

Page 29: TAMU#81095

CHRONIC HEPATITISTherapy for inflammation/necrosis

• Remove cause – not symptomatic

– Decrease copper absorption with zinc

gluconate (10 mg elemental zinc/kg)

– Administer with tuna fish

– Measure blood zinc levels

• need > 200 mcg/dl to be therapeutic

• > 2,000 mcg/dl may cause hemolysis

Page 30: TAMU#81095

CHRONIC HEPATITISTherapy for inflammation/necrosis

Decrease the inflammatory response

• Corticosteroids

– prednisolone (not prednisone)

– budesonide

• Cytotoxic drugs (azathioprine)

• Cyclosporine

Page 31: TAMU#81095

HEPATOPROTECTIVE THERAPY

• What this therapy does NOT do ...

• What this therapy does do ...

Page 32: TAMU#81095

• Ursodeoxycholic acid (15 mg/kg qd)

– A hydrophilic bile acid

– Displaces toxic, hydrophobic bile acids

• Hydrophobic bile acids are detergents

– damage hepatocyte & mitochondrial

membrane

– Food enhances bioavailability

HEPATOPROTECTIVE THERAPY

Page 33: TAMU#81095
Page 34: TAMU#81095
Page 35: TAMU#81095

• s-adenosyl L-Methionine (SAMe)

– Human studies

• acute intrahepatic cholestasis

• alcoholic liver disease

– Veterinary studies

• healthy animals

• acetaminophen, prednisolone

HEPATOPROTECTIVE THERAPY

Page 36: TAMU#81095

• Milk thistle (Silymarin)

– Silybin is the active fraction

– Antioxidant, antifibrotic, anti-inflammatory

– Effective for Amanita, aflatoxin,

acetaminophen, ethanol, ischemic

damage

HEPATOPROTECTIVE THERAPY

Page 37: TAMU#81095

CHRONIC HEPATITISPrognosis

• Potentially ominous signs:

– ascites

– icterus

– severe hypoalbuminemia

– apparent cirrhosis

– hepatic encephalopathy

Page 38: TAMU#81095

CHRONIC HEPATITISPrognosis

• < 4 months for those with poor

prognostic signs

• > 1.5 years for others

Page 39: TAMU#81095

WHAT ABOUT THE

“NORMAL” DOG THAT HAS

AN INCREASED ALT?

Page 40: TAMU#81095

M ore likely to bevery im portant

A LT persistently> 3-4 X norm al

O ften notreal im portant

A LT < 3-4 X norm alOR

transiently increased

C linically normal dog w ithincreased A LT as only abnormality

Page 41: TAMU#81095

M ore likely to bevery im portant

A LT persistently> 3-4 X norm al

O ften notreal im portant

A LT < 3-4 X norm alOR

transiently increased

C linically normal dog w ithincreased A LT as only abnormality

Page 42: TAMU#81095

WHAT ABOUT THE

“NORMAL” DOG THAT JUST

HAS AN INCREASED SAP?

Page 43: TAMU#81095

Yearly recheck

O w ner contentw ith > 99%+ certainty

B iopsy the liver

O w ner N O T contentw ith > 99%+ certainty

Look for Tumors/HepatopathyAbdom inal U ltrasound

Look for HyperadrenocorticismH istory/Physica l Exam ination

Clinically norm al dog w ith increasedSAP as only significant clinical

pathology abnorm ality

Page 44: TAMU#81095

Yearly recheck

O w ner contentw ith > 99%+ certainty

B iopsy the liver

O w ner N O T contentw ith > 99%+ certainty

Look for Tumors/HepatopathyAbdom inal U ltrasound

Look for HyperadrenocorticismH istory/Physica l Exam ination

Clinically norm al dog w ith increasedSAP as only significant clinical

pathology abnorm ality

Page 45: TAMU#81095

Yearly recheck

O w ner contentw ith > 99%+ certainty

B iopsy the liver

O w ner N O T contentw ith > 99%+ certainty

Look for Tumors/HepatopathyAbdom inal U ltrasound

Look for HyperadrenocorticismH istory/Physica l Exam ination

Clinically norm al dog w ith increasedSAP as only significant clinical

pathology abnorm ality

Page 46: TAMU#81095

WHAT ABOUT SCOTTISH

TERRIERS?

Page 47: TAMU#81095

TAMU #96276

Sig: 4 yr M Cocker Spaniel

CC: Swollen abdomen

HPI: Dark yellow urine and depression

were first noted by owners 2

days ago

Today the dog has an obviously

swollen abdomen

PE: Depressed and has ascites

Page 48: TAMU#81095

TAMU #96276

BUN = 57 mg/dl (8-29)Creatinine = 2.4 mg/dl (< 2.0)Sodium = 128 mEq/L (138-148)Potassium = 4.9 mEq/L (3.5-5.0) Total protein = 6.5 gm/dl (5.5-7.0)Albumin = 2.0 gm/dl (2.5-4.4)ALT = 72 IU/L (< 130)SAP = 128 IU/L (< 147)Bilirubin = 1.6 mg/dl (< 0.8)

Page 49: TAMU#81095
Page 50: TAMU#81095

Hepatic Biopsy

GUIDANCE TYPE OF BIOPSY

Blind Fine needle aspirate

Ultrasound

Page 51: TAMU#81095

TAMU # 72927

Sig: 9 yr M(c) Cat 6 kg

CC: Weight loss & vomiting

HPI: Poor appetite & vomiting bile for

6 weeks; has lost 2.3 kg

ALT = 202 U/L

SAP = 427 U/L

PE: No significant findings

Page 52: TAMU#81095

TAMU # 72927

Cytology of liver (ultrasound guided):

“no cytologic evidence of active

inflammation or neoplasia … mild

hepatic lipidosis”

Page 53: TAMU#81095

TAMU # 72927

Histopathology:

“Moderate to severe multifocal

lymphocytic cholangiohepatitis with

cholestasis; mild hepatic lipidosis”

Page 54: TAMU#81095
Page 55: TAMU#81095

Hepatic Biopsy

GUIDANCE TYPE OF BIOPSY

Blind Fine needle aspirate

Ultrasound Core needle

Page 56: TAMU#81095
Page 57: TAMU#81095

“Diagnostic Accuracy of Tru Cut

Needle Biopsy Compared to

Wedge Biopsy of the Liver” by

Cole et al, JAVMA 220:1483, 2002

100 dogs and 22 cats

51.6% discordance between results

Page 58: TAMU#81095
Page 59: TAMU#81095
Page 60: TAMU#81095

Hepatic Biopsy

GUIDANCE TYPE OF BIOPSY

Blind Fine needle aspirate

Ultrasound Core needle

Laparoscopy Wedge

Surgery

Page 61: TAMU#81095
Page 62: TAMU#81095
Page 63: TAMU#81095
Page 64: TAMU#81095

TAMU #162500

Abdominal U/S: “The liver, pancreatic

region, GI tract, kidneys and adrenals

were unremarkable.”

Page 65: TAMU#81095
Page 66: TAMU#81095

TAMU #139804

Abdominal U/S: “The liver and spleen

were unremarkable. ... Essentially

normal abdominal ultrasound.”

Page 67: TAMU#81095
Page 68: TAMU#81095

TAMU #128604

Abdominal U/S: “A sonographic

examination of the abdomen was

performed and revealed no significant

abnormal findings”

Page 69: TAMU#81095
Page 70: TAMU#81095

TAMU #168184

Abdominal U/S: “... sludge within the

gall bladder. This was organizing and

probably the early development of a

cholelith. The remainder of the liver was

considered normal ... Changes in the gall

bladder consistent with sludge and

possibly early cholelith development.

Otherwise, normal abdomen. ”

Page 71: TAMU#81095
Page 72: TAMU#81095

TAMU #147332

Abdominal U/S: “The liver appeared to

be of normal size, texture and

echogenicity. ... Essentially normal

abdominal ultrasound.”

Page 73: TAMU#81095
Page 74: TAMU#81095

Ultrasound and the Liver

• 40% (dog) to 60% (cat) accurate in

diffuse hepatic diseases

• Cannot distinguish benign from

malignant nodules

Page 75: TAMU#81095
Page 76: TAMU#81095

Modified laparoscopy

JAVMA 187:1032, 1985

Page 77: TAMU#81095
Page 78: TAMU#81095

Sterile

Not sterile

Page 79: TAMU#81095

Sterile towel

Page 80: TAMU#81095
Page 81: TAMU#81095
Page 82: TAMU#81095
Page 83: TAMU#81095
Page 84: TAMU#81095
Page 85: TAMU#81095